A study will support the benefit of certain supplements in one type of patient but show harm when the same supplements are taken by another group or people with different medical conditions. The key is to know the difference.
Read Whole Story
There's ample evidence that state officials have put the lazy in laissez faire when it comes to providing effective oversight of Pearson's massive contract.
Google's proposed acquisition of ITA and potential dominance in the online travel market raises substantial questions I would ask as a former antitrust regulator.
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.